Merck decision to drop odanacatib lifts UCB/Amgen pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Eikon Therapeutics closes $148M financing to develop super-resolution microscopy
06 May 2021
California-based firm to integrate advanced optics, machine learning with biochemistry; its target application is drug discovery.
Eikon focuses on live-cell super-resolution microscopy for drug discovery.Eikon Therapeutics, a Hayward, California-based company focused on live-cell super-resolution microscopy and engineering for drug discovery, has this week announced that it has closed a $148 million Series A financing round.
The funding is led by The Column Group with participation from Foresite Capital, Innovation Endeavors and Lux Capital. Eikon also announced the appointment of Roger M. Perlmutter, MD, PhD, as its new Chief Executive Officer.
Eikon Therapeutics Closes $148M Financing Round, Names CEO | Business | May 2021 photonics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from photonics.com Daily Mail and Mail on Sunday newspapers.